CNS & Neurological Disorders-Drug Targets

Papers
(The median citation count of CNS & Neurological Disorders-Drug Targets is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Meet the Editorial Board Member117
Meet the Regional Editor77
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation66
Breaking Barriers: Advanced Pharmacological Mediators for Neuropsychiatric Disorders61
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis61
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease39
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 38
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives36
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus36
Recent Trends in Physical Therapy Interventions and Neuromodulation Techniques to Improve Neurorehabilitation36
Targeting JNK3: An In-silico Approach to Uncover Potential Therapeutics for Alzheimer’s Disease33
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis33
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease30
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment30
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies30
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota29
Recent Advancement of Pyrazole Scaffold Based Neuroprotective Agents: A Review29
Molecular and Biochemical Pathways Encompassing Diabetes Mellitus and Dementia26
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders25
Pathological Insights into Neurodegenerative and Neurodevelopmental Disorders: Perspectives for the Development of Novel Treatment Approaches24
Microbiota-Gut-Brain Axis: A Novel Paradigm in the Neurobiology of Anxiety24
From Microbes to Minds: The Impact of Gut Bacteria on Infant Cognitive Growth24
Precision Neurodegeneration: Integrating Molecular Mechanisms, Biomarkers, and Targeted Therapeutics22
Gut-Brain Axis and Neurological Disorders-How Microbiomes Affect our Mental Health21
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound20
Danshensu Enhances Cerebral Angiogenesis in Mice by Regulating the PI3K/Akt/Mtor/VEGF Signaling Axis20
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature20
AI-Driven Biomarker Discovery in Motor-Related Neurodegenerative Diseases20
Are Lysosomes Potential Therapeutic Targets for Parkinson’s Disease?20
Insights into the Diagnosis, Treatment, and Management of Prion Diseases20
Clozapine in a Young Female with Drug-Resistant Schizophrenia: A Case Report of Development of Serositis19
A Critical Analysis of Quercetin as the Attractive Target for the Treatment of Parkinson's Disease19
Breaking Through Barriers: The Transformative Potential of Nanomedicine in Overcoming Drug Delivery Challenges for Psychiatric Disorders19
WITHDRAWN: Nigella Fixed Oil Mitigates Memory Impairment in a Rat-Aged Model of Cognitive Decline; A Pivotal Role of BDNF and CREB Signaling Pathways in the Hippocampus18
Black phosphorus in neurological disorders: Current therapeutic applications, mechanisms, and future prospects18
Vasospasm in Pediatric Subarachnoid Hemorrhage18
A Systematic Review of Updated Mechanistic Insights Towards Alzheimer’s Disease18
Neuropharmacological Activity of the New Piperazine Derivative 2-(4-((1- Phenyl-1H-Pyrazol-4-yl)Methyl)Piperazin-1-yl)Ethyl Acetate is Modulated by Serotonergic and GABAergic Pathways17
High-frequency Repetitive Transcranial Magnetic Stimulation (rTMS) Accelerates onset Time of Beneficial Treating Effects and Improves Clinical Symptoms of Depression17
Nanoformulations: A Progressive Strategy for Alleviating Migraine through Nasal Route17
Solid Lipid Nanoparticle Mediated Intranasal Drug Delivery for Brain Targeting: A Comprehensive Review17
Analysis of Concentrations of Monomethyl Fumarate in Patients with Multiple Sclerosis: Result from Routine Health Care17
IL-33 is Required for Behavioral Deficits in a Murine Model of Systemic Lupus Erythematosus Through Regulation of Microglia Glycolysis17
An Overview of the Natural Neuroprotective Agents for the Management of Cognitive Impairment Induced by Scopolamine in Zebrafish (Danio rerio)16
Navigated Transcranial Magnetic Stimulation (nTMS) based Preoperative Planning for Brain Tumor Treatment15
Induced Depressive Disorder Following the First Dose of COVID-19 Vaccine15
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models15
Decoding the Gut-Brain Axis in Alzheimer's Disease: Emerging Perspectives14
Comparison of the Sedative Effect of Ketamine, Magnesium Sulfate, and Propofol in Patients Undergoing Upper Gastrointestinal Endoscopy: Double-Blinded Randomized Clinical Trial14
Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review14
Genetic Predisposition and Severity of Eating Disorders- A Review14
Evolutionary Unmasking Resuscitative Therapeutics Potential of Centhaquin Citrate in Hypovolemic Shock14
Natural Products as Bioactive Agents in the Prevention of Dementia14
Impact of Structured Physical Exercise on Adolescent Depression: A Comprehensive Meta-Analysis of RCTs14
Epilepsy: Modern Treatment Approaches, Clinical Aspects, and Patent Status14
An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease13
Bis-iodine-labeled Curcumin as a Potential CT Imaging Agent for β-amyloid Plaques in the Brain13
Transcription Factor Pet-1/FEV as a Potential Therapeutic Target in Anxiety and Depressive Disorders13
Neuroprotective and Anti-Inflammatory Effects of Pioglitazone on Parkinson's Disease: A Comprehensive Narrative Review of Clinical and Experimental Findings13
Acknowledgements to Reviewers13
Targeting Blood-Brain Barrier Damage with Nanotechnology in the Fight Against Neurodegenerative Diseases13
The Landscape of Randomized Clinical Trial Meta-analyses on Statins for Aneurysmal Subarachnoid Hemorrhage: A Scoping Review13
Fisetin and Neurodegeneration: From Preclinical Studies to Potential Clinical Applications13
Obesity and Depression: Common Link and Possible Targets13
Effect of Dual-task Exercise on Cognition and Dual-task Cost in the Elderly with Mild Cognitive Impairment: A Randomized Pilot Study13
Phosphodiesterase 2 and Its Isoform A as Therapeutic Targets in the Central Nervous System Disorders12
Role of G-Proteins and GPCR-Mediated Signalling in Neuropathophysiology12
COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?12
Sweroside Modulates Oxidative Stress and Neuroplasticity-Related Gene Expression in Scopolamine-Treated Zebrafish12
Effects of Hesperetin Early Intervention on Brain Neurons and Microglia in APPswe/PS1dE9 Mice12
Emerging Treatments for Subarachnoid Hemorrhage12
Mechanism of Glioblastoma Treatment Targeting Growth Factors: IGF-I Case Using Gene, Immune, Phytochemicals, and Nanotechnologies12
Approaches for Ear-targeted Delivery Systems in Neurosensory Disorders to avoid Chronic Hearing Loss Mediated Neurological Diseases12
The Effect of a Novel Antibody-based Drug, Prospekta, on Brain Electrical Activity in Mice12
Circadian Rhythm and Risk of Hemorrhagic Transformation after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic Review11
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series11
Lithium Chloride Rescues Dopaminergic Neurons in a Parkinson’s Disease Rat Model Challenged with Rotenone11
Tetrandrine Attenuates Cerebral Ischemia/Reperfusion Injury by Regulating Th17/Treg Balance and Mediating PI3K/Akt Pathway in Mice, Based on Network Pharmacology Analysis11
Acknowledgements to Reviewers11
Pharmacotherapy in SAH: Clinical Trial Lessons11
The Potential Role of Dopamine Pathways in the Pathophysiology of Depression: Current Advances and Future Aspects11
Inhibiting Monoamine Oxidase in CNS and CVS would be a Promising Approach to Mitigating Cardiovascular Complications in Neurodegenerative Disorders11
Prospects for Neurotrophic Factor-Based Early Intervention in Schizophrenia: Lessons Learned from the Effects of Antipsychotic Drugs on Cognition, Neurogenesis, and Neurotrophic Factors11
WITHDRAWN: Neurological Studies Of Herbal Medicinal Plants For The Treatment Of Memory Impairment: A Review10
Lorcaserin: Worthy of Further Insights? Results from Recent Research10
One-Trial Appetitive Learning Tasks for Drug Targeting10
Rationalizing the Use of Polyphenol Nano-formulations in the Therapy of Neurodegenerative Diseases10
Valproate Exposure as an In vitro Model for Studying Morpho-Molecular Features of ASD: A Systematic Review10
Insights into the Molecular Mechanisms of Neurodegenerative Diseases: Exploring Molecular Pathways and the Therapeutic Potential of Rivastigmine10
Focused Ultrasound-activated Extracellular Vesicles–nanoparticle Hybrids for Targeted Brain Drug Delivery: Engineering Strategies and Translational Outlook10
Stroke and Vascular Cognitive Impairment: The Role of Intestinal Microbiota Metabolite TMAO10
Neuroprotection or Sex Bias: A Protective Response to Traumatic Brain Injury in the Females10
Cannabidiol in Epilepsy: Restoring Locomotion and Seizure Control10
Rethinking Catatonia: New Insights from the Autism Spectrum10
Nanotechnological Advances in the Treatment of Epilepsy9
Therapeutic Potential of Myricetin in the Treatment of Neurological, Neuropsychiatric, and Neurodegenerative Disorders9
Neurological Complications Caused by Human Immunodeficiency Virus (HIV) and Associated Opportunistic Co-infections: A Review on their Diagnosis and Therapeutic Insights9
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease9
Neurological Manifestations Following Traumatic Brain Injury: Role of Behavioral, Neuroinflammation, Excitotoxicity, Nrf-2 and Nitric Oxide9
Therapeutic Potential of Nutritional Modulators in Traumatic Brain Injury: A Systematic Review9
Endophenotypes and Pathway Phenotypes in Neuro-psychiatry: Crossdisciplinary Implications for Diagnosis9
The Protective Role of L-carnitine on Psychosocial Stress-induced Changes in Gene Expression and Protein Levels of Matrix Metalloproteinases, Serum Corticosterone in a Rat Model9
Nicotine Abuse and Neurodegeneration: Novel Pharmacogenetic Targets to Aid Quitting and Reduce the Risk of Dementia9
Rationale and Development of Tavapadon, a D1/D5-Selective Partial Dopamine Agonist for the Treatment of Parkinson’s Disease9
Benzodiazepines and Sleep Architecture: A Systematic Review9
Traumatic Brain Injury in COVID-19 Patients with the Manifestation of Paroxysmal Sympathetic Hyperactivity and Cytokine Storm9
Challenges in Brain Drug Delivery for Neurodegenerative Disorders and Recent Trends: A Review9
Circadian Rhythms and Sleep Disorders Associated to Major Depressive Disorder: Pathophysiology and Therapeutic Opportunities9
Circular RNAs in Alzheimer’s Disease: A New Perspective of Diagnostic and Therapeutic Targets9
Design and Molecular Docking Studies of N-Mannich Base Derivatives of Primaquine Bearing Isatin on the Targets involved in the Pathophysiology of Cerebral Malaria9
Nanoparticle-Based Approaches for Glioblastoma Treatment: Advances and Future Prospects9
The Peripheral Profile of the Chitinase 3-like-1 in Benign Multiple Sclerosis – A Single Centre’s Experience9
Atorvastatin's Reduction of Alzheimer's Disease and Possible Alteration of Cognitive Function in Midlife as well as its Treatment8
Preface8
Neurotoxicity of Endogenous Neurotoxin Salsolinol in Parkinson's Disease8
Bibliometric Analysis of Neutrophil Extracellular Traps in Stroke: Research Trends and Hotspots8
Ameliorating Effects of Virgin Coconut Oil (VCO) on Nicotine Dependence and Quality of Life in Smokers8
Anaesthesia-induced Changes in Genomic Expression Leading to Neurodegeneration8
The Role of Ca2+ Permeable AMPA Receptors in Neurodegeneration, Neurotoxicity, and Neuroinflammation8
Coenzyme Q10 in the Treatment of Attention Deficit Hyperactivity Disorder in Children: A Randomized Controlled Trial8
Role of Unani Polyherbal Formulations in the Treatment of Diseases with Special Reference to Neurodegenerative Disorders8
Neurodegenerative Disorders and the Current State, Pathophysiology, and Management of Parkinson’s Disease8
Valproic Acid and Celecoxib Enhance the Effect of Temozolomide on Glioblastoma Cells7
Acute Peripheral Facial Nerve Palsy in Children and Adolescents: Clinical Aspects and Treatment Modalities7
Imbalance of Th1 and Th2 Cytokines and Stem Cell Therapy in Pathological Pain7
Lactose and Casein Cause Changes on Biomarkers of Oxidative Damage and Dysbiosis in an Experimental Model of Multiple Sclerosis7
An Insight into Medicinal Chemistry and SAR Studies of Cholinesterase and BACE-1 Inhibitors for Alzheimer's Disease7
Early Detection of Glioma: Investigating Inflammatory Markers (CRP), Kidney, and Liver Function7
The Role of the cGAS-STING Pathway in Central Nervous System Diseases7
Protective Effects of Memantine Against Acute Stress-Induced Fear Memory and Synaptic Dysfunction via NMDA Receptor Antagonism7
Synergistic Roles of Neuropeptide S and Environmental Enrichment in Preclinical Huntington’s Disease Depression Models7
An Overview of Acute Flaccid Myelitis7
Brain-Derived Neurotrophic Factor – The Protective Agent Against Neurological Disorders7
Parkinson’s Disease: A Progressive Neurodegenerative Disorder and Structure-Activity Relationship of MAO Inhibitor Scaffolds as an Important Therapeutic Regimen7
Nicotine Dependence-Induced Withdrawal Syndrome: Mechanistic Insights and Therapeutic Implications7
Peripheral Vascular Disease is Associated with Impaired Activities of Daily Living in the Elderly with Dementia: A Prospective Study7
Cyclodextrins-Phospholipids Complex Loaded Nanofibers for Improved Oral Bioavailability and Brain Targeting for Management of Stress and Anxiety7
Flow Diversion for the Management of Posterior Circulation’s Intracranial Aneurysms7
Integrating Synthesis, Pharmacological Activity, and Molecular Modeling to Explore 1,2,4-Triazine Fused Thiazolidin-4-one Derivatives as GABAA Receptor Modulators7
Association between Frequency of Seizures and Number of Antiseizure Medications (ASM) in Patients with Epilepsy7
In Schizophrenia, Chronic Fatigue Syndrome- and Fibromyalgia-Like Symptoms are Driven by Breakdown of the Paracellular Pathway with Increased Zonulin and Immune Activation-Associated Neurotoxicity7
Foresee Novel Targets for Alzheimer’s Disease by Investigating Repurposed Drugs7
Targeting Vascular Dementia: Pharmacological Mechanisms and Therapeutic Strategies7
Role of Imaging Genetics in Alzheimer’s Disease: A Systematic Review and Current Update6
KCNQ2 Channel as a Druggable Epilepsy Target: Advances in Pharmacological Modifiers6
The Endocannabinoid System as a Biomarker for Diagnostic and Therapeutic Applications in Depression and Anxiety6
Role of Lipocalin-2 in N1/N2 Neutrophil Polarization After Stroke6
β-Amyloid Pathways in Alzheimer's Disease: Mechanisms and Therapeutic Targets6
Acknowledgements to Reviewers6
Recent Development of Zolmitriptan Formulation in Migraine Therapy: Production, Metabolism and Pharmaceutical Aspects6
Strategic Neurodelivery of Psychedelic Compounds: Bridging Molecular Pharmacology with Therapeutic Innovation in CNS Disorders6
The Possible Protective Effect of Taurine on Bisphenol Induced Structural Changes on the Cerebral Cortex of Rats: Histological and Immunohistochemical Study6
How Do Abnormalities in the Cerebrospinal Fluid Impact Neuropsychology with Progressing Age?6
Abnormality of Voltage-Gated Sodium Channels in Disease Development of the Nervous System. A Review Article6
Preface6
From Anesthetic to Neuroprotector: Multi-Omics Reveals Ketamine's Previously Unexplored Neuroprotective Role in Alzheimer's Disease6
WITHDRAWN: Neuroprotective Effect of 3,3′-Diindolylmethane and ɑ-Naphthoflavone, Aryl Hydrocarbon Receptor Modulators, in an Experimental Model of Ischemic Stroke6
Meet the Editorial Board Member6
A Causal-Pathway Phenotype of Chronic Fatigue Syndrome due to Hemodialysis in Patients with End-Stage Renal Disease6
Pre-clinical Aspects and Contemporary Treatments of Parkinson’s Disease6
Meet the Editorial Board Member6
Ferroptosis Targeting Offers a Therapeutic Strategy for Subarachnoid Hemorrhage6
Metabolic Disorder Therapeutics and their Effects on Memory6
Notopterygium incisum Root Extract (NRE) Alleviates Epileptiform Symptoms in PTZ-Induced Acute Seizure Mice6
A Systematic Review of Recent Advances in Drug Delivery to the Central Nervous System Through Prodrug Approach6
Genetic Causes of Alzheimer’s Disease and the Neuroprotective Role of Melatonin in its Management5
A Comprehensive Review on Therapeutic Potential of Chrysin in Brain Related Disorders5
Role of Vitamins in Neurodegenerative Diseases: A Review5
Evaluation of Associated Genes with Traumatic Pain: A Systematic Review5
The Role of Monoamine Oxidase B Inhibitors in the Treatment of Parkinson’s Disease - An Update5
Recent Trends in Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer’s Disease5
Nordihydroguaiaretic Acid Affects Undifferentiated and Differentiated Neuroblastoma Cells Differently through Mechanisms that Impact on Cell Viability5
Dietary Xylitol Supplement Ameliorated AD-related Neuronal Injury by Regulating Glucose Metabolism Relevant Amino Acids in Mice5
Comparison of Safety and Effectiveness between Levetiracetam and Phenytoin in the Treatment of Pediatric Status Epilepticus: A Meta- Analysis5
Neuroinflammation, Autophagy, and Neurodegeneration: Mechanisms and Therapeutic Insights5
Targeted Nanotechnology Approaches to Bypass the Blood–brain Barrier in Neurodegenerative Disorders5
Dopamine Depletion in Parkinson’s Disease and Therapeutic Options5
Targeted Delivery of Montelukast for the Treatment of Alzheimer’s Disease5
Ablation of Shank1 Protects against 6-OHDA-induced Cytotoxicity via PRDX3-mediated Inhibition of ER Stress in SN4741 Cells5
Clinical Benefits of Therapeutic Interventions Targeting Mitochondria in Parkinson’s Disease Patients5
Speech as a Biomarker for Depression5
Exploring LRRK2-dependent Mechanisms in Parkinson’s Disease Therapy5
Hypoxia-inducible Factor-1α Pathway in Cerebral Ischemia: From Molecular Mechanisms to Therapeutic Targets5
Implication of HPA-axis Dysfunction in Depression: From Neurobiological Mechanisms to Future Treatment Strategies5
Immunotherapeutics for AD: A Work in Progress5
Cell-Free DNA, a Noninvasive Biomarker for Prediction and Detection of Neurodegenerative Diseases, New Insights, and Perspectives5
Subarachnoid Hemorrhage4
Hypothesis-Driven Insights and Clinical Trial Updates in Alzheimer’s Disease Pathogenesis4
Sleep-Related Disorders in Parkinson's Disease: Mechanisms, Diagnosis, and Therapeutic Approaches4
Hesperetin Early Intervention Reduces Β-Amyloid Production in APP/PS1 Mice by Decreasing Beta and Gamma-Secretase Enzyme4
The Neuroprotective Role of BCG Vaccine in Movement Disorders: A Review4
The Participation of Ca2+ Channels in Epilepsy: A Bibliometric Analysis of the Scientific Literature in Latin America4
Tirofiban-Nimodipine Combination Therapy for Early Neurological Deterioration in Small Artery Occlusion Stroke: A Retrospective Cohort Study4
APOE4 is a Risk Factor and Potential Therapeutic Target for Alzheimer's Disease4
Fluoride-induced Neurodevelopmental Toxicity- AMPK as a Possible Target4
Role of Alpha-7-Nicotinic Acetylcholine Receptor in Alzheimer's Disease4
The Effectiveness of Transcranial Magnetic Stimulation in Treating Apraxia4
Pharmacogenetics of Carbamazepine: A Systematic Review on CYP3A4 and CYP3A5 Polymorphisms4
Effect of Natural Plant Products on Alzheimer’s Disease4
Natural Compounds as Inhibitors of Aβ Peptide and Tau Aggregation4
Phytotherapeutics against Alzheimer’s Disease: Mechanism, Molecular Targets and Challenges for Drug Development4
Reciprocal Interaction of Pain and Brain: Plasticity-induced Pain, Pain-induced Plasticity, and Therapeutic Targets4
Exploring Therapeutic Strategies: The Relationship between Metabolic Disorders and FOXO Signalling in Alzheimer's Disease4
Meet the Frontier Section Editor4
Pharmacology and Pharmacogenomics of Anti-Migraine Drugs4
Unraveling the Emerging Niche Role of Extracellular Vesicles (EVs) in Traumatic Brain Injury (TBI)4
Immunotherapeutic Approaches for the Treatment of Neurodegenerative Diseases: Challenges and Outcomes4
User-Centered Design of Neuroprosthetics: Advancements and Limitations4
Pharmacological Breakthroughs with Extracellular Vesicles-Based Nanomedicine: A Targeted Strategy to Cross the Blood-Brain Barrier in Alzheimer’s Disease4
The Use of Benzodiazepines and Risk of Incident Type 2 Diabetes in the General Population with Insomnia4
Nanoparticles as Powerful Tools for Crossing the Blood-brain Barrier4
Oxytocin Effect in Adult Patients with Autism: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials4
Modeling of Parkinson's Disease in Different Models4
Re-Profiling and Re-purposing of FDA-Approved AntiViral Agents Against Neurological Targets of Memory and Cognition: Molecular Docking and Simulation Approach4
A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches4
Biotechnological Perspectives on GSK-3β and Hyperprolactinemia: Implications for the Progression of Alzheimer’s Disease4
Nutritional Support System (NSS) as a New Therapeutic Strategy for Cerebral Palsy4
Comprehensive Perspective Towards the Management of Proteinopathies by Elucidating Protein Misfolding and Aggregation4
Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 14
The Effects and Mechanism of Scutellaria baicalensis Georgi Stems and Leaves Flavonoids on Myelin Sheath Degeneration Induced by Composite Aβ in Rats3
The Interplay between PKC and ELAV4 in the CNS: An Emerging Therapeutic Axis for Dementia Management3
Neuroinflammatory and Synaptic Roles of Glial Cells in Autism Spectrum Disorder3
Synergistic Neuroimmune Modulation by Cannabidiol and Probiotics for Therapeutic Advancement in CNS Disorders: A Systematic Review3
A Concise Review of Common Plant-derived Compounds as a Potential Therapy for Alzheimer's Disease and Parkinson's Disease: Insight into Structure-Activity-Relationship3
Electrolyte Imbalance and Neurologic Injury3
Preface3
Smartphone Addiction among Students and its Harmful Effects on Mental Health, Oxidative Stress, and Neurodegeneration towards Future Modulation of Anti-Addiction Therapies: A Comprehensive Survey base3
Trends and Perspectives in the Rational Management of CNS Disorders3
Meet the Associate Editorial Board Member3
Reconnoitering the Potential of the Pharmacogenomics Approach in the Management of Alzheimer's Disease: A Review3
A Potential Strategy for Treating Parkinson's Disease Through Intranasal Nanoemulsions3
Common microRNAs in Epilepsy and Migraine: Their Possibility as Candidates for Biomarkers and Therapeutic Targets during Comorbid Onset of Both Conditions3
Meet the Co-Editor3
L-Ala-L-Gln Suppresses Hypoxic Phenotype and Fibrogenic Activity of Rat Perineurial Fibroblasts3
Recent Updates on Lipid Landscapes in Neonatal and Adult Neurological Disorders: Advancing Mass Spectrometry and Lipidomics for Disease Insight: A Systematic Review3
MicroRNAs as Molecular Modulators in Stroke: Pathogenic Mechanisms and Therapeutic Avenues3
Perspective on Cav-1 for its Potential as Newer Therapeutics for Parkinson’s Disease3
Mechanistic Insights into Terpenoid-Based Therapy for Parkinson’s Disease3
Meet the Editorial Board Member3
Enhanced Neuroprotection in Experiment Multiple Sclerosis through Combined Rosiglitazone and Probiotic-loaded Solid Lipid Nanoparticles: Modulation of Cellular Signaling Pathways3
Immune Cell Infiltration and Key Gene Identification in Alzheimer's Disease and Sleep Deprivation3
The Development of a PBPK Model for Atomoxetine Using Levels in Plasma, Saliva and Brain Extracellular Fluid in Patients with Normal and Deteriorated Kidney Function3
Neuroprotective Potential of Bacopa monnieri: Modulation of Inflammatory Signals3
Transdermal Therapeutic Systems for the Treatment of Alzheimer's Disease: A Patent Review3
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the Microbiota Become a Viable Therapeutic Strategy?3
Amyotrophic Lateral Sclerosis (ALS): An Overview of Genetic and Metabolic Signaling Mechanisms3
Role of Autophagy and Mitophagy in Neurodegenerative Disorders3
Bcl-2 as a Double-edged Sword for the Treatment of Multiple Sclerosis: A Systematic Review3
Research Progress on Intervention Strategies Targeting the Gut-Brain Axis in Alzheimer's Disease3
Vitamin D and Neurological Health: Unraveling Risk Factors, Disease Progression, and Treatment Potential3
0.27889609336853